Radiologix losses widen
For the fourth quarter 2003, imaging services provider Radiologix reported service fee revenue of $66 million versus $64 million in the same period of the previous year, a 3.1% increase. But the company noted a net loss of $3 million for the quarter
For the fourth quarter 2003, imaging services provider Radiologix reported service fee revenue of $66 million versus $64 million in the same period of the previous year, a 3.1% increase. But the company noted a net loss of $3 million for the quarter compared with a net loss of $1.6 million for the fourth quarter 2002 and a loss from continuing operations of $1.3 million compared with a continuing operations loss of $585,000 in the fourth quarter of 2002. In fiscal year 2003, service-fee revenue fell 5.6% to $257 million from $272.2 million the previous year. The company incurred a net loss of $8 million for fiscal year 2003 compared with net income of $10.8 million for the year before. For fiscal year 2003, loss from continuing operations was $1.1 million, compared with income from continuing operations of $11.5 million for fiscal 2002.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
